Medipharm Labs Corp T.LABS

If Medipharm continues to improve QOQ

[mdjbrown]

revenue / profitability, does it become an attractive takeover target by one of the big medical mj players already in Germany, Australia, and Brazil?  


If so, what price would be acceptable to shareholders?

[Starkicker]

Only because I've seen this as a trend in ither sectors I'm invested in, a purchase could be made for an additional 50-80% above current SP then LABS is taken private by the buyer.

[Solid1]

10 $ per share 

[Romulus22]

Exactly. NO WAY us shareholders should settle for 50-80% over todays ridiculously manipulated share price which is made worse by the leadership keeping developments under wraps. 

[alleyesonme]

Retail shareholders voting turnout is very low, I'd be surprised to see more than 20% of the issued shares casting proxy..low turnout year after year, no wonder shareholders appear to be an afterthought...over two years of stagnant share price is long enough, it's time for them to show some accountability to shareholders....I voted withhold...the business is going well but not enough is

[Romulus22]

Well Said! I have been a long term shareholder that has averaged down to .30 after all this time. I'll be damned if mgt pulls something that shafts its shareholders. They haven't shown regard to us. They also do so by not doing anything to let the public know what they are doing. Is this some kind of top secret Manhattan Project?? That is why for the first time I voted withold with all my

[QContinuum1]

There is no way the current BoD accepts and proposes to shareholders a takeout at anywhere near current valuation, if and only if, the business projections are accurate.  If they are, then the $10 price or whatever, while rich, isn't necessarily that much if everything lines up and the market sees LABS as a bonafide 'pharma' company.  $10 is a lot, but I could realistically

[mdjbrown]

and therein lies the conundrum for shareholders QC1 Management has publicly stated they believe the current market cap of Medipharm is very undervalued, yet short of quarterly required disclosure they are relatively selective with any positive announcements even though from the outside looking in, it would appear there are a lot of moving parts that could be promoted as positive events to

[subaru1]

Mdjbrown, the market is talking loudly, Labs worth $0,07 today, we can do all the speculaqtion in the world and by the way there has been speculation here since over 3 years and nothing has happen to the stock price. We will need a big surprise with the revenue to move over $0,10 even with a positive EBITDA. For a takeover target i don't think so Labs is a public company since over 5 years and